Salipro Biotech at COVID-19 Virtual Partnering Event

Written By Jens Frauenfeld

Salipro Biotech is looking forward to meeting with partners at the COVID-19 Virtual Partnering Event and accelerating the discovery of new therapeutics against COVID-19.

The Salipro platform enables the development of drugs against full-length SARS-CoV-2 (S, M or E) or host (ACE2, immune signaling receptors, etc.) membrane proteins.
Event link

Jens Frauenfeld
Previous

Antibiotic resistance research using Salipro
Next

Muscle protein structure solved using Salipro and snake venom